Jack Weinstein Email and Phone Number
Jack Weinstein work email
- Valid
- Valid
- Valid
- Valid
- Valid
Jack Weinstein personal email
Jack Weinstein phone numbers
Seasoned C-suite leadership with broad expertise in private as well as public life science, biopharmaceutical and healthcare services companies, encompassing all phases from pre-revenue to established growth enterprises through IPO. Roles have included CEO, CFO, VP of Business Development and healthcare investment banker. As CEO, CFO and investment banker, completed a variety of corporate finance transactions, including public and private financings, and mergers and acquisitions in multiple industries.As a CFO, executed merger and acquisitions, in- and out-licensing opportunities managed treasury, IR, human resources, risk management, IT and intellectual property portfolios.Former member of Board of Directors for three privately held companies, including two as Board Chairman.Jack Weinstein is a Registered Representative of Finalis Securities LLC Member FINRA / SIPC. Finalis Securities LLC and Avalon Securities Ltd. are separate, unaffiliated entities
Avalon Securities Ltd
View-
Managing DirectorAvalon Securities Ltd Nov 2023 - Present
-
Senior AdvisorAvalon Securities Ltd Nov 2016 - Jul 2024
-
Chief Executive OfficerRelief Therapeutics Holding Ag Dec 2022 - Nov 2023Geneve, Ch• Member of senior management team of this publicly traded Swiss and US biopharmaceutical company focusing on the development of therapies to treat rare diseases with high unmet medical needs.• Supervised the establishment of a US commercial team, launched first US commercial product.• Executed reverse stock split to increase attractiveness of stock to institutional investors. -
Chief Financial Officer & TreasurerRelief Therapeutics Holding Ag Oct 2020 - Dec 2022Geneve, Ch• Raised $85 million in equity on favorable terms.• Executed two acquisitions and in-licensed two products, transforming Relief from a development stage to a commercial stage biopharmaceutical company.• Responsible for all investor and investment banking outreach, while managing all internal financial activities.
-
Chairman Of The BoardLutris Pharma Jul 2021 - Jan 2022 -
Chief Financial OfficerBalluun May 2016 - Nov 2016Sunnyvale, California, Us -
President And FounderSterlington Group, Inc. 2012 - Nov 2016Provide strategic, operations and “CFO” consulting services, including merger and acquisitions advisory, budgeting, and raising public and private equity and debt for middle-market companies.• Developed relationships with overseas manufacturers for healthcare client working on a large IP licensing deal and training contract to tie-in with manufacturer’s product line.• Introduced celebrity branding start-up to entertainment executive that is spearheading development and go-to-market strategy for company.• Negotiating licensing agreement for biopharmaceutical client; developed business plans that helped secure interest from specialty pharmaceutical company.• Created acquisition strategy for environmental services client; introduced client to potential high-volume, multi-site customer for a series of high-level negotiations.• Established financial infrastructure and systems for start-up client and introduced company to a pipeline of potential new accounts.• Performed due diligence, prepared financial projections and made acquisition proposal for jewelry retailer.• Spearheading equity funding for digital media company; created presentation decks and executive summary.Mr. Weinstein holds FINRA Series 79 and 63 Licenses.
-
Vice President Of Business Development, Treasurer And Chief Financial OfficerCatalyst Pharmaceuticals, Inc. Oct 2004 - Dec 2011Coral Gables, Florida, Us• Executed successful Nasdaq Global Market IPO (CPRX) and five subsequent registered direct common stock offerings.• Identified potential strategic partners and participated in discussions to out-license CPRX products and in-license new products.• Leveraged relationships with investment banks like First Albany (became Broadpoint Capital), Stifel Nicolaus, Roth Capital, Rodman & Renshaw, Merriman Curhan Ford for IPO and subsequent deals.• Recruited and developed Corporate Controller and Chief Accounting Officer; assisted CEO with the hiring of a VP of Regulatory Affairs.• Identified opportunity to enhance contact management and implemented proprietary system to streamline system and then migrate to Salesforce.com.• Instituted formal budgeting process integrated with Catalyst accounting system which helped control costs.• Identified strategic alliance in the UK and held high-level discussions with multi-national company.• Supervised development of Sarbanes Oxley and XBRL implementations; sourced SOX Consultant.• Hired and supervised the creation and management of Catalyst’s third and fourth generation of Web Sites at costs significantly less than market.• Replaced high-cost health plan with a high-deductible policy and self-insurance for deductibles.• Authored policies for finance, product liabilities, D&O and health insurance. -
Managing Director And Head Of Healthcare Investment BankingAvalon Securities Ltd 2002 - 2004• Led successful rights offering, private equity placement and successful IPO for a pharmaceutical client.• Provided CFO services and support, fundraising and management consulting for client company.• Managed sourcing and execution of investment banking transactions.
-
Managing Director And Head Of Healthcare Investment BankingLadenburg Thalmann 1999 - 2002Us• Hired to start, staff and lead the Healthcare Investment Banking Group.• Raised company profile in the healthcare space through conference programming and interaction with healthcare analysts.• Managed sourcing and execution of investment banking transactions. -
Managing Director, Head Of Healthcare Investment Banking And Partner Of Private Equity FundGruntal & Lepercq De Neuflize 1986 - 1998Transactions of note:Sole managed $20 million IPO for Ribogene (Questcor). Company sold in 2014 to Mallinckrodt for $5.6 billion.$20.5 million secondary public offering and two PIPEs ($12.4 million and $3.9 million) for LifeCell Corporation, a Gruntal and then Ladenburg client. Company sold in 2008 to Kinetic Concepts Inc. for $1.7 billion.$4.2 million PIPE for BEI Medical Systems. Company sold in 2002 to Boston Scientific for $95 million. $6.0 million PIPE for AVANIR Pharmaceuticals.Executed $20 million leveraged recapitalization of NFS, a recreational food services company.Advised MSE, a technology and environmental development company in sale of civil engineering business. Transaction value -- over $3 million.
Jack Weinstein Education Details
-
Harvard Business SchoolEmphasis In Finance And Service Operations -
University Of MiamiMusic Industry Management & Operations
Frequently Asked Questions about Jack Weinstein
What company does Jack Weinstein work for?
Jack Weinstein works for Avalon Securities Ltd
What is Jack Weinstein's role at the current company?
Jack Weinstein's current role is Executive management and BOD experience with life science companies. Former roles as CEO, CFO and VP of business development. Have completed a variety of corporate finance and M&A transactions..
What is Jack Weinstein's email address?
Jack Weinstein's email address is jw****@****rth.com
What is Jack Weinstein's direct phone number?
Jack Weinstein's direct phone number is (877) 280*****
What schools did Jack Weinstein attend?
Jack Weinstein attended Harvard Business School, University Of Miami.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial